Recombinant Thrombin Activatable Fibrinolysis Inhibitor (TAFI)

Recombinant Thrombin Activatable Fibrinolysis Inhibitor (TAFI)

Size

10ug

Catalog no.

RPA615Ra01

Price

318 EUR

Buy

Accurate Molecular Mass(KD)

NA

Isoelectric Point

8.7

Predicted Molecular Mass(KD)

31.0kDa

Purity

≥ 95%

Group

recombinants

Protein length

Gly164~His417

Tag

N-terminal His-Tag

Traits

Freeze-dried powder

Expression System

Prokaryotic expression

Source

Prokaryotic expression

Organism species

Rattus norvegicus (Rat)

Research Area

Metabolic pathway;Hematology;

Additional source

Recombinants or rec. proteins

Application

Positive Control; Immunogen; SDS-PAGE; WB.

Item Name

Thrombin Activatable Fibrinolysis Inhibitor

Buffer Formulation

PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.

Alternative Names

CPB2; CPU; PCPB; Carboxypeptidase B2; Plasma Carboxypeptidase B; Carboxypeptidase U

Description

Tissue, pathway, proteinase, peptidase, protease ,acrosin, lipoprotein, activator, caspase, trypsin, papain, esterase inhibitors are proteins or receptor ligands or receptor antagonists that bind to an enzyme receptor and decreases its activity. Since blocking an enzyme's activity can kill a pathogen or correct a metabolic imbalance, many drugs are enzyme inhibitors. Not all receptor antagonist that bind to enzymes are inhibitors; enzyme activator ligands or agonists bind to enzymes and increase their enzymatic activity, while enzyme substrates bind and are converted to products in the normal catalytic cycle of the enzyme.